AI-guided pathology analysis can help predict immunotherapy response in rare cancers | Newswise

Researchers have developed an artificial intelligence tool that analyzes digitized pathology slides to predict how patients with rare cancers will respond to immunotherapy. By identifying specific tissue patterns that human pathologists may overlook, the model offers a more precise method for determining which patients are likely to benefit from treatment. This approach could improve clinical decision-making for rare conditions where limited data typically makes it difficult to predict therapeutic outcomes.